US Stock MarketDetailed Quotes

STRO Sutro Biopharma

Watchlist

2.650
-0.040-1.49%

Close Nov 29 13:00 ET

2.790
+0.140+5.28%

Post 17:01 ET

218.52MMarket Cap-1709P/E (TTM)

Sutro Biopharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-92.57%-64.52M

130.31%9.46M

-6.15%-64.74M

-3,245.00%-111.62M

158.97%14.07M

-150.87%-33.5M

-879.13%-31.2M

-73.00%-60.99M

104.35%3.55M

-10.58%-23.86M

Net income from continuing operations

1.01%-48.79M

-24.64%-48.02M

-16.31%-58.21M

10.41%-106.79M

189.80%31.07M

-152.89%-49.28M

-48.10%-38.52M

-27.97%-50.05M

-12.95%-119.2M

9.26%-34.59M

Depreciation and amortization

3.45%1.8M

3.41%1.79M

9.04%1.76M

19.79%6.82M

13.29%1.73M

20.93%1.74M

23.91%1.73M

21.70%1.62M

17.46%5.69M

16.20%1.53M

Other non cash items

27.21%9.4M

617.39%8.79M

1,268.47%8.59M

475.63%16.82M

835.93%7.58M

854.26%7.39M

125.18%1.23M

-20.91%628K

-52.56%2.92M

-55.95%810K

Change In working capital

-290.27%-7.12M

514.23%48.37M

31.93%-16.62M

-132.92%-34.38M

-210.30%-21.58M

-95.32%3.74M

-21.92%7.88M

-367.38%-24.41M

692.54%104.41M

524.68%19.57M

-Change in receivables

104.45%295K

19,425.40%24.35M

273.68%4.78M

-642.15%-28.96M

-571.20%-19.45M

-107.67%-6.63M

99.85%-126K

-458.20%-2.75M

177.46%5.34M

3,429.03%4.13M

-Change in prepaid assets

-393.20%-2.55M

-95.83%306K

67.81%-2.39M

103.08%109K

-10.95%-669K

130.35%868K

2,603.07%7.33M

-3,601.89%-7.42M

10.48%-3.54M

-204.87%-603K

-Change in payables and accrued expense

-127.88%-1.35M

-323.37%-6.01M

-20.95%-2.66M

464.21%30.11M

476.77%24.78M

658.59%4.84M

-19.30%2.69M

-54.13%-2.2M

-37.75%5.34M

5.04%4.3M

-Change in other current liabilities

-16.88%-1.66M

-79.23%-1.55M

-79.57%-1.5M

-341.57%-4.59M

-398.78%-1.46M

-396.25%-1.42M

-280.71%-862K

-285.59%-837K

169.60%1.9M

125.98%490K

-Change in other working capital

-130.55%-1.86M

2,788.99%31.27M

-32.51%-14.84M

-132.56%-31.06M

-320.14%-24.78M

289.68%6.08M

-101.26%-1.16M

-114.27%-11.2M

856.15%95.37M

2,259.33%11.25M

Cash from discontinued investing activities

Operating cash flow

-92.57%-64.52M

130.31%9.46M

-6.15%-64.74M

-3,245.00%-111.62M

158.97%14.07M

-150.87%-33.5M

-879.13%-31.2M

-73.00%-60.99M

104.35%3.55M

-10.58%-23.86M

Investing cash flow

Cash flow from continuing investing activities

229.18%147.29M

-221.49%-80.38M

-4.96%64.11M

88.80%-3.92M

37.93%-23.51M

-46.11%-114.02M

38.07%66.16M

104.51%67.45M

64.01%-35.02M

-282.29%-37.88M

Net PPE purchase and sale

-152.44%-828K

52.87%-756K

52.65%-446K

45.09%-4.32M

57.20%-1.44M

55.56%-328K

27.09%-1.6M

39.34%-942K

48.72%-7.86M

-32.72%-3.37M

Net investment purchase and sale

230.28%148.12M

-217.50%-79.62M

-5.62%64.55M

101.44%391K

36.07%-22.07M

-47.08%-113.69M

35.21%67.76M

98.04%68.39M

66.86%-27.17M

-248.11%-34.52M

Net other investing changes

----

0.00%9K

----

Cash from discontinued investing activities

Investing cash flow

229.18%147.29M

-221.49%-80.38M

-4.96%64.11M

88.80%-3.92M

37.93%-23.51M

-46.11%-114.02M

38.07%66.16M

104.51%67.45M

64.01%-35.02M

-282.29%-37.88M

Financing cash flow

Cash flow from continuing financing activities

117.72%1.02M

-29.91%96.49M

-139.15%-3.43M

184.71%137.55M

-125.57%-3.13M

-119.23%-5.74M

2,409.77%137.66M

1,052.37%8.76M

1,383.81%48.31M

2,315.22%12.22M

Net issuance payments of debt

--0

-30.66%-4.08M

-33.33%-12.5M

0.00%-3.13M

---3.13M

---9.38M

---3.13M

Net common stock issuance

--0

9,110.59%96.53M

--0

-78.73%11.97M

--0

-87.81%1.05M

--10.92M

803,957.14%56.27M

219,314.29%15.35M

Proceeds from stock option exercised by employees

14.36%1.09M

--0

-27.14%1.03M

25.73%2.37M

--0

37.86%954K

--0

18.97%1.41M

-55.74%1.88M

-99.81%1K

Net other financing activities

97.93%-74K

-100.03%-37K

17.07%-374K

29,412.74%135.72M

--0

-7,038.00%-3.57M

1,074,807.69%139.74M

-5.87%-451K

53.09%-463K

--0

Cash from discontinued financing activities

Financing cash flow

117.72%1.02M

-29.91%96.49M

-139.15%-3.43M

184.71%137.55M

-125.57%-3.13M

-119.23%-5.74M

2,409.77%137.66M

1,052.37%8.76M

1,383.81%48.31M

2,315.22%12.22M

Net cash flow

Beginning cash position

-61.16%91.65M

4.31%66.08M

45.74%70.14M

53.83%48.13M

-15.30%82.71M

195.01%235.97M

112.76%63.34M

53.83%48.13M

-84.89%31.29M

209.23%97.65M

Current changes in cash

154.67%83.79M

-85.19%25.57M

-126.71%-4.07M

30.72%22.01M

74.63%-12.57M

-967.65%-153.26M

243.77%172.62M

1,105.82%15.22M

109.58%16.84M

-16,802.73%-49.53M

End cash Position

112.12%175.44M

-61.16%91.65M

4.31%66.08M

45.74%70.14M

-15.30%82.71M

195.01%235.97M

112.76%63.34M

53.83%48.13M

Free cash flow

-93.15%-65.34M

126.52%8.7M

-5.25%-65.19M

-2,590.44%-115.93M

146.38%12.63M

-151.95%-33.83M

-508.97%-32.8M

-68.26%-61.93M

95.56%-4.31M

-12.91%-27.23M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-92.57%-64.52M	130.31%9.46M	-6.15%-64.74M	-3,245.00%-111.62M	158.97%14.07M	-150.87%-33.5M	-879.13%-31.2M	-73.00%-60.99M	104.35%3.55M	-10.58%-23.86M
Net income from continuing operations	1.01%-48.79M	-24.64%-48.02M	-16.31%-58.21M	10.41%-106.79M	189.80%31.07M	-152.89%-49.28M	-48.10%-38.52M	-27.97%-50.05M	-12.95%-119.2M	9.26%-34.59M
Depreciation and amortization	3.45%1.8M	3.41%1.79M	9.04%1.76M	19.79%6.82M	13.29%1.73M	20.93%1.74M	23.91%1.73M	21.70%1.62M	17.46%5.69M	16.20%1.53M
Other non cash items	27.21%9.4M	617.39%8.79M	1,268.47%8.59M	475.63%16.82M	835.93%7.58M	854.26%7.39M	125.18%1.23M	-20.91%628K	-52.56%2.92M	-55.95%810K
Change In working capital	-290.27%-7.12M	514.23%48.37M	31.93%-16.62M	-132.92%-34.38M	-210.30%-21.58M	-95.32%3.74M	-21.92%7.88M	-367.38%-24.41M	692.54%104.41M	524.68%19.57M
-Change in receivables	104.45%295K	19,425.40%24.35M	273.68%4.78M	-642.15%-28.96M	-571.20%-19.45M	-107.67%-6.63M	99.85%-126K	-458.20%-2.75M	177.46%5.34M	3,429.03%4.13M
-Change in prepaid assets	-393.20%-2.55M	-95.83%306K	67.81%-2.39M	103.08%109K	-10.95%-669K	130.35%868K	2,603.07%7.33M	-3,601.89%-7.42M	10.48%-3.54M	-204.87%-603K
-Change in payables and accrued expense	-127.88%-1.35M	-323.37%-6.01M	-20.95%-2.66M	464.21%30.11M	476.77%24.78M	658.59%4.84M	-19.30%2.69M	-54.13%-2.2M	-37.75%5.34M	5.04%4.3M
-Change in other current liabilities	-16.88%-1.66M	-79.23%-1.55M	-79.57%-1.5M	-341.57%-4.59M	-398.78%-1.46M	-396.25%-1.42M	-280.71%-862K	-285.59%-837K	169.60%1.9M	125.98%490K
-Change in other working capital	-130.55%-1.86M	2,788.99%31.27M	-32.51%-14.84M	-132.56%-31.06M	-320.14%-24.78M	289.68%6.08M	-101.26%-1.16M	-114.27%-11.2M	856.15%95.37M	2,259.33%11.25M
Cash from discontinued investing activities
Operating cash flow	-92.57%-64.52M	130.31%9.46M	-6.15%-64.74M	-3,245.00%-111.62M	158.97%14.07M	-150.87%-33.5M	-879.13%-31.2M	-73.00%-60.99M	104.35%3.55M	-10.58%-23.86M
Investing cash flow
Cash flow from continuing investing activities	229.18%147.29M	-221.49%-80.38M	-4.96%64.11M	88.80%-3.92M	37.93%-23.51M	-46.11%-114.02M	38.07%66.16M	104.51%67.45M	64.01%-35.02M	-282.29%-37.88M
Net PPE purchase and sale	-152.44%-828K	52.87%-756K	52.65%-446K	45.09%-4.32M	57.20%-1.44M	55.56%-328K	27.09%-1.6M	39.34%-942K	48.72%-7.86M	-32.72%-3.37M
Net investment purchase and sale	230.28%148.12M	-217.50%-79.62M	-5.62%64.55M	101.44%391K	36.07%-22.07M	-47.08%-113.69M	35.21%67.76M	98.04%68.39M	66.86%-27.17M	-248.11%-34.52M
Net other investing changes	----	----	----	----	----	----	----	----	0.00%9K	----
Cash from discontinued investing activities
Investing cash flow	229.18%147.29M	-221.49%-80.38M	-4.96%64.11M	88.80%-3.92M	37.93%-23.51M	-46.11%-114.02M	38.07%66.16M	104.51%67.45M	64.01%-35.02M	-282.29%-37.88M
Financing cash flow
Cash flow from continuing financing activities	117.72%1.02M	-29.91%96.49M	-139.15%-3.43M	184.71%137.55M	-125.57%-3.13M	-119.23%-5.74M	2,409.77%137.66M	1,052.37%8.76M	1,383.81%48.31M	2,315.22%12.22M
Net issuance payments of debt	--0	--0	-30.66%-4.08M	-33.33%-12.5M	0.00%-3.13M	0.00%-3.13M	0.00%-3.13M	---3.13M	---9.38M	---3.13M
Net common stock issuance	--0	9,110.59%96.53M	--0	-78.73%11.97M	--0	--0	-87.81%1.05M	--10.92M	803,957.14%56.27M	219,314.29%15.35M
Proceeds from stock option exercised by employees	14.36%1.09M	--0	-27.14%1.03M	25.73%2.37M	--0	37.86%954K	--0	18.97%1.41M	-55.74%1.88M	-99.81%1K
Net other financing activities	97.93%-74K	-100.03%-37K	17.07%-374K	29,412.74%135.72M	--0	-7,038.00%-3.57M	1,074,807.69%139.74M	-5.87%-451K	53.09%-463K	--0
Cash from discontinued financing activities
Financing cash flow	117.72%1.02M	-29.91%96.49M	-139.15%-3.43M	184.71%137.55M	-125.57%-3.13M	-119.23%-5.74M	2,409.77%137.66M	1,052.37%8.76M	1,383.81%48.31M	2,315.22%12.22M
Net cash flow
Beginning cash position	-61.16%91.65M	4.31%66.08M	45.74%70.14M	53.83%48.13M	-15.30%82.71M	195.01%235.97M	112.76%63.34M	53.83%48.13M	-84.89%31.29M	209.23%97.65M
Current changes in cash	154.67%83.79M	-85.19%25.57M	-126.71%-4.07M	30.72%22.01M	74.63%-12.57M	-967.65%-153.26M	243.77%172.62M	1,105.82%15.22M	109.58%16.84M	-16,802.73%-49.53M
End cash Position	112.12%175.44M	-61.16%91.65M	4.31%66.08M	45.74%70.14M	45.74%70.14M	-15.30%82.71M	195.01%235.97M	112.76%63.34M	53.83%48.13M	53.83%48.13M
Free cash flow	-93.15%-65.34M	126.52%8.7M	-5.25%-65.19M	-2,590.44%-115.93M	146.38%12.63M	-151.95%-33.83M	-508.97%-32.8M	-68.26%-61.93M	95.56%-4.31M	-12.91%-27.23M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data